The board of directors at Morphic Therapeutic have a wide range of experience in the pharmaceutical industry. They have worked as senior directors, directors, and scientists at various companies such as Loxo Oncology, Onyx Pharmaceuticals, ChemGenex Pharmaceuticals, and Portola Pharmaceuticals. They have also been educated at some of the top universities in the world, including UNSW, where they studied biochemistry and molecular genetics.
Albert Robichaud
Scientific Advisor
Amir Nashat
Director
Gustav Christensen
Director
Joseph P. Slattery
Director
Martin Edwards
Director
Nisha Nanda
Director
Norbert Bischofberge...
Director
Otello Stampacchia
Director
Scott L. Friedman
Advisor
Shelia Violette
Scientific Advisor
Susannah Gray
Director
Timothy Springer
Director
Ulrich H. Von Andria...
Scientific Advisor
Yury V. Popov
Scientific Advisor
View all